United Therapeutics Corp (NASDAQ:UTHR)

185.33
Delayed Data
As of Apr 20
 +0.14 / +0.08%
Today’s Change
84.63
Today|||52-Week Range
190.29
+43.12%
Year-to-Date

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 152.00, with a high estimate of 198.00 and a low estimate of 92.00. The median estimate represents a -17.98% decrease from the last price of 185.33.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.30
Sales
$354.4M
Reporting Date
Apr 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.83%
 
 
 
 
 
 
Growthannually 54.89%
 
 
 
 
 
 

Sales

Growthquarterly 2.32%
 
 
 
 
 
 
Growthannually 19.26%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account